News Announcement

Aurobindo Pharma: Closure of Trading Window

This is to inform that as per the Companys Internal Code of Conduct to Regulate Monitor and Report Trading by Designated Persons the Trading Window for dealing in the securities of the Company would remain closed for all designated persons including promoters directors key managerial personnel employees connected persons and their immediate relatives with effect from January 1 2021 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the third quarter and nine months period ending on December 31 2020.

The date of Board Meeting for declaration of the financial results of the Company for the third quarter and nine months period ending on December 31 2020 will be intimated in due course.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.